English Overview
Dr. Anderson Ribeiro will interview Prof. Forst (Germany) and Prof. Bonora (Italy) on an overview of the impact of different doses of dulaglutide and the implication from clinical studies to the clinical practice.
This Activity for
- Resident / Fellow
- Physician
What I will learn?
• Welcome and Speaker's Introduction
Patient case introduction
• Debate: What would guidelines recommend for this patient?
• Patient case re-introduction with higher HbA1c and BMI
• Debate: Is Trulicity still an option for this patient considering the high HbA1c and BMI?
• Debate: What would the rational be for choosing Trulicity over Basal Insulin or other GLP-1 in this patient?
• Debate: Are there other factors you would consider when choosing a treatment for this patient?
• Live Polling, Q&A, and Closing
Patient case introduction
• Debate: What would guidelines recommend for this patient?
• Patient case re-introduction with higher HbA1c and BMI
• Debate: Is Trulicity still an option for this patient considering the high HbA1c and BMI?
• Debate: What would the rational be for choosing Trulicity over Basal Insulin or other GLP-1 in this patient?
• Debate: Are there other factors you would consider when choosing a treatment for this patient?
• Live Polling, Q&A, and Closing
Recorded Programs
Dulaglutide, From Clinical Studies to Clinical Practice Part 1
Due Date 07/06/2022
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Dulaglutide, From Clinical Studies to Clinical Practice Certificate
Certificate |
Certificate | Free |
VAT 15% Included
